INTEGRATING RADIOTHERAPY WITH EGFR ANTAGONISTS AND OTHER MOLECULAR THERAPEUTICS FOR THE TREATMENT OF HEAD AND NECK CANCER

Ítems similars

• Prediction of Neck Dissection Requirement After Definitive Radiotherapy for Head and Neck Squamous Cell Carcinoma
  per: Thariat, Juliette, et al.
  Publicat: (2012)
• Molecular Target Approaches in Head and Neck Cancer: EGFR and Beyond
  per: Harari, Paul M., et al.
  Publicat: (2009)
• Integrating EGFR Assay with Clinical Parameters Improves Risk Classification for Relapse and Survival in Head and Neck Squamous Cell Carcinoma
  per: Chung, Christine H., et al.
  Publicat: (2010)
• Resistance to EGFR inhibitors: Molecular determinants and the enigma of head and neck cancer
  per: Morris, Luc G.T., et al.
  Publicat: (2011)
• ROS-Mediated Therapeutic Strategy in Chemo-/Radiotherapy of Head and Neck Cancer
  per: Huang, Gan, et al.
  Publicat: (2020)